Viewing stories from August, 2024
Starpharma Annual Report and Full-Year Financial Results
Starpharma, an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient, today releases its annual report and full-year financial results for the year ended 30 June 2024.
Appendix 4G and Corporate Governance Statement (ASX Announcement)
Starpharma (ASX: SPL, OTCQX: SPHRY), an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient, today releases its Appendix 4G, Key Disclosures to Corporate Governance Principles and Recommendations, and Corporate Governance Statement, in accordance with ASX Listing Rules 4.7.3 and 4.10.3.